Torray Investment Partners 13F, Q3 2025

Torray · quarter ending 30 September 2025 · filed 22 October 2025 · SEC CIK 98758

$737.02M
Filed US book
99
Positions
4.2%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q3 2025

The 25 largest of 99 positions. Weights are against the whole filed book. Changes are in shares held, against the Q2 2025 filing.

CompanyTickerValue% of bookvs Q2 2025
Broadcom LimitedAVGO$31.11M4.2%-37% shares
Phillips 66PSX$28.41M3.9%+3% shares
Royalty Pharma Plc$24.80M3.4%+2% shares
Hewlett Packard Ent Ser C ConvHPE 7.625 09/01/27$24.40M3.3%new
AbbvieABBV$23.53M3.2%+7% shares
Home DepotHD$23.51M3.2%+3% shares
Blackstone GroupBX$23.42M3.2%+3% shares
CNA FinancialCNA$23.35M3.2%+19% shares
Texas InstrumentsTXN$21.00M2.9%-13% shares
AmgenAMGN$20.47M2.8%+4% shares
ChevronCVX$20.31M2.8%+3% shares
UnitedHealth GroupUNH$19.72M2.7%+16% shares
PfizerPFE$19.19M2.6%+16% shares
American ExpressAXP$19.15M2.6%unchanged
MicrosoftMSFT$18.40M2.5%-3% shares
NextEra EnergyNEE$18.00M2.4%new
PepsiCoPEP$17.22M2.3%new
ProLogisPLD$17.18M2.3%+8% shares
EOG ResourcesEOG$17.13M2.3%+6% shares
Amazon.comAMZN$16.47M2.2%-4% shares
EquinixEQIX$16.46M2.2%new
Lennar Corp Cl BLEN/B$16.24M2.2%+4% shares
Marsh McLennanMRSH$14.11M1.9%unchanged
AppleAAPL$13.60M1.9%-4% shares
Berkshire Hathaway BBRK/B$12.38M1.7%-34% shares

What changed since Q2 2025

Against the Q2 2025 filing, Torray Investment Partners opened 10 new positions, added to 35, trimmed 31, left 23 unchanged and exited 10. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

  • HPE 7.625 09/01/27$24.40M
  • NEE$18.00M
  • PEP$17.22M
  • EQIX$16.46M
  • VUG$4.15M
  • Fabrinet$2.46M
  • EVLV$1.24M
  • TSLA$822.7K

and 2 more

Exited

  • GDwas $10.99M
  • SNPSwas $8.63M
  • WRBwas $6.45M
  • DLRwas $4.20M
  • MOwas $3.98M
  • LMTwas $3.24M
  • Ansyswas $2.54M
  • Blueprint Medicineswas $2.13M

and 2 more

Added to

  • PSX+3%$28.41M
  • Royalty Pharma Plc+2%$24.80M
  • ABBV+7%$23.53M
  • HD+3%$23.51M
  • BX+3%$23.42M
  • CNA+19%$23.35M
  • AMGN+4%$20.47M
  • CVX+3%$20.31M

and 27 more

Trimmed

and 23 more

Other quarters

Source: SEC Form 13F-HR, accession 0001193125-25-246260, filed by TORRAY INVESTMENT PARTNERS LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.